Funds managed by affiliates of Apollo Global Management, Inc. (together with its consolidated subsidiaries, “Apollo”) (NYSE: APO), a leading global alternative investment manager, announced Thursday that they have agreed to acquire Covis Pharma BV (“Covis Pharma” or “Covis”), a global specialty pharmaceutical company, from an affiliate of Cerberus Capital Management, L.P. (“Cerberus”), a global leader in alternative investing. Terms of the transaction were not disclosed. Subject to antitrust approval, the transaction is expected to close by the end of the 1st quarter of 2020. Covis is focused on marketing and distributing an array of branded products used to treat chronic and life-threatening medical issues and improve patient outcomes in various therapeutic areas including respiratory, cardiovascular, gastroenterology and central nervous system diseases.
Read the full article: Funds Managed by Affiliates of Apollo Global Management to Acquire Covis Pharma from Cerberus //
Source: https://www.globenewswire.com/news-release/2020/02/06/1981193/0/en/Funds-Managed-by-Affiliates-of-Apollo-Global-Management-to-Acquire-Covis-Pharma-From-Cerberus.html